Key facts
- It has raised $36.7M across 3 recorded rounds; the latest was Early Stage VC ($22.4M) in Mar 2024.
- Notable investors include US National Science Foundation, United States Department of War, VU Venture Partners, LIFTT, Catalytic Impact Foundation — 15 tracked in total.
- X-Therma has filed 3 Form Ds with the SEC since 2021, most recently Mar 2024 ($22.4M sold to 39 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for X-Therma
Funding rounds
3 roundsAbout X-Therma
Provider of biopreservation technology intended for long-term storage of biological materials. The company leverages proprietary peptoid technology to inhibit ice crystal formation, allowing sub-zero storage of cells, tissues, and organs while maintaining their functionality and viability, enabling healthcare and research institutions to preserve samples effectively, supporting advancements in regenerative medicine and transplantation.
- Sector
- Healthcare
- HQ
- Hercules, CA, United States
- Founded
- 2014
- Employees
- 33
- Website
- x-therma.com/
- Ownership
- Privately Held (backing)
X-Therma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in X-Therma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on X-Therma in its N-PORT filings yet. We sweep new filings monthly.